In this Section
204407 Race and risk for sexually transmitted infections (STIs) in women with and without borderline personality disorder (BPD)
Monday, November 9, 2009: 9:10 AM
The aim of this study was to investigate prevalence and correlates of STIs in a psychiatric sample of women with and without Borderline Personality Disorder (BPD). To date, we enrolled 215 women aged 18-40 years (M=26.9, SD=6.6); 114 women with BPD and 101 women who met DSM-IV criteria for current, non-psychotic Axis-I disorder, primarily mood disorders. We oversampled African-American (AA) women (34%, compared to 13% in the Pittsburgh area) because little is known about BPD in AA women, who tend to experience disproportionately high rates of STIs. All participants completed the Structured Clinical Interview for DMS-IV Axis I and II diagnoses (SCID-I and -II) and were interviewed about their sexual and reproductive history. Fifty-two percent of the sample reported an STI such as Chlamydia (24%), HPV (18%), or trichomonas (16%). AA women reported coitarche at an earlier age than non-AA women, but were not more likely to have been in the sex trade, or have riskier sexual partners. Nonetheless, regression analyses indicate that the AA women in this sample were at significantly higher risk for multiple STIs than the non-AA women, even after controlling for other significant covariates (age, SES, age at coitarche, BPD scores). The present findings indicate that, even within a high-risk psychiatric sample, AA women are at greater risk for STIs than other American women. The results of separate analyses conducted on the 2 groups highlighted different risk factors for AA and non-AA women in this sample, and may help better target interventions.
Keywords: STD, African American
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I conduct epidemiological research in this area at the University of Pittsburgh (Western Psychiatric Institute and Clinic). I have a PhD in developmental psychology and am completing a postdoctoral fellowship in epidemiology. I am the primary author on this abstract because I developed the research hypotheses, conducted all statistical analyses, and drafted the abstract. My co-authors provided access to the dataset and helped me revise the abstract for submission.
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.